DOI:
10.1055/s-00029029
Journal of Pediatric Intensive Care
LinksClose Window
References
Galanaud JP, Pelletier-Fleury N, Logerot-Lebrun H, Lambert T.
Determinants of drug costs in hospitalised patients with haemophilia: impact of recombinant activated factor VII.
Pharmacoeconomics 2003;
21 (10) 699-707
We do not assume any responsibility for the contents of the web pages of other providers.